A - Human Necessities – 61 – P
Patent
A - Human Necessities
61
P
A61P 19/08 (2006.01) C07D 207/26 (2006.01) C07D 307/33 (2006.01)
Patent
CA 2552713
The present invention relates to a novel class of compounds mainly, substituted leucinamide-carboxylate derivatives of formula (I) wherein X is O or NR9, Y is CR1R2, -SO2, C=O or NR9; Z is CR1R2, O, S, -SO2 or NR9 and each G is independently a CR1CR2 and pharmaceutical compositions thereof. Said compounds are cathepsin cysteine protease inhibitors, including but not limited to, inhibitors of cathepsin K, L, S and B. These compounds are useful for treating and preventing cathpesin dependent conditions in which inhibition of bone resorption is indicated, such as osteoporosis.
L'invention concerne une nouvelle classe de composés principalement des dérivés de leucinamide-carboxylate substituée de la formule (I), dans laquelle S représente O ou NR?9¿, Y représente CR?1¿R?2¿, -SO¿2?, C=O ou NR?9¿; Z représente CR?1¿R?2¿, O, S, -SO¿2? ou NR?9¿ et chaque G représente indépendamment un CR?1¿R?2¿ et ses compositions pharmaceutiques. Ces composés sont des inhibiteurs de cathépsine cystéine protéase, notamment des inhibiteurs des cathépsines K, L, S et B, et sont utilisés dans le traitement et la prévention d'états dépendant de la cathépsine où l'inhibition de la résorption osseuse, telle que l'ostéoporose, est indiquée.
Bayly Christopher
Crane Sheldon N.
Leger Serge
Merck Frosst Canada & Co.
Merck Frosst Canada Ltd.
Norton Rose Canada S.e.n.c.r.l.,s.r.l./llp
LandOfFree
Cathepsin cysteine protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cathepsin cysteine protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cathepsin cysteine protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1926430